HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.

AbstractBACKGROUND:
A mass Entamoeba histolytica infection recurred despite repeated treatments with metronidazole at a rehabilitation institution for individuals with intellectual impairments.
METHODS:
Diloxanide furoate was administered to improve intractable intestinal amoebiasis after a recurring amoebic infection that tends to occur via coprophagy in mentally disabled individuals infected with E. histolytica at an institution (the prevalence rate and positive serology rate were 38.2 and 67.1%, respectively). The therapeutic effect of the drugs was judged by microscopic stool examination and an E. histolytica antigen detection kit.
RESULTS:
The mass infection was eliminated through the administration of metronidazole and subsequent use of diloxanide furoate.
CONCLUSIONS:
Combination therapy successfully cured and prevented transmission of the mass E. histolytica infection at the institution.
AuthorsTsukasa Fujishima, Shoichi Nishise, Masahiro Ichihara, Seiki Kobayashi, Tsutomu Takeuchi
JournalChemotherapy (Chemotherapy) Vol. 56 Issue 4 Pg. 348-52 ( 2010) ISSN: 1421-9794 [Electronic] Switzerland
PMID20720419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 S. Karger AG, Basel.
Chemical References
  • Amebicides
  • Furans
  • Metronidazole
  • diloxanide furoate
Topics
  • Amebicides (therapeutic use)
  • Drug Resistance
  • Drug Therapy, Combination
  • Dysentery, Amebic (drug therapy, epidemiology, parasitology)
  • Entamoeba histolytica (drug effects, genetics, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Feces (parasitology)
  • Female
  • Furans (therapeutic use)
  • Humans
  • Japan (epidemiology)
  • Male
  • Metronidazole (therapeutic use)
  • Persons with Mental Disabilities
  • Rehabilitation Centers
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: